You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股异动 | 药明生物(2269.HK)涨逾5% 有望入选恒指成份股
格隆汇 08-13 10:03
格隆汇8月13日丨药明生物(2269.HK)涨逾5%,报163.9港元,总市值2224.6亿港元。周五盘后,恒生指数公司将公布恒生系列指数季度定期审议结果,其中便包括港股市场旗舰指数,如恒生和国企指数。中金公司发文称,初步测算,阿里巴巴、美团点评、安踏体育、阿里健康、药明生物、华润啤酒排在恒生指数选择顺位前列。阿里巴巴涨近2%,华润啤酒涨0.58%。药明生物此前发布公告称,集团预期截至2020年6月30日止六个月所录得的归属于公司权益股东的利润相比于去年同期归属于公司权益股东的利润增长58%以上。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account